课题基金 / 基金详情

Studies on the biosynthetic mechanism of platelet-activating factor and its physiological significance in alveolar macrophages

Studies on the biosynthetic mechanism of platelet-activating factor and its physiological significance in alveolar macrophages
肺泡巨噬细胞血小板激活因子生物合成机制及其生理意义的研究
批准号:
62480425
负责人:
WAKU Keizo
金额:
$4.16万
依托单位国家:
日本
项目类别:
Grant-in-Aid for General Scientific Research (B)
财政年份:
1987
资助国家:
日本
项目状态:
已结题
起止时间:
1987 至 1988

项目摘要

项目成果

WAKU Keizo的其他基金

相似基金

相关文献

中文摘要
翻译
1. 烷基醚磷脂酰化机理的研究。我们研究了1-烷基-甘油酰胆碱(GPC)在兔肺泡巨噬细胞微粒体中的酰化机制,以1-烷基-甘油酰胆碱为受体,以二酰基-GPC(包括2位的^<14 bb0 c -花生四烯酸)为酰基供体。这种转酰基化反应不需要CoA、ATP或Mg^<2+>。C-20脂肪酸,特别是花生四烯酸(20:4)和二十二碳六烯酸(22:6)是该酶反应的良好底物。烷基醚磷脂中花生四烯酸的释放及乙酰基残基掺入1-烷基- gpc。磷脂酶A_2作用于乙醚胆碱甘油磷脂(CGP)产生的Lyso血小板活化因子(Lyso PAF, 1-烷基- gpc)被乙酰转移酶或转酰基酶乙酰化或酰基化,具有竞争性。乙酰转移酶的比活性为474 mol /min/10^6个细胞裂解物(acetylCoA; 100 m), A23187刺激细胞后比活性提高2-3倍。转酰基酶的活性为98摩尔/分/10^6个细胞裂解液,细胞刺激未见转酰基酶活性显著增加。另一方面,在不添加外源乙酰辅酶a的情况下,乙酰转移酶的活性与乙酰辅酶a的浓度有很大关系。因此,在这种情况下,lyso PAF似乎主要是由转酰基酶以20:4的比例进行酰基化,而不是乙酰转移酶。这些酶或底物在细胞中的定位应在下一步进行研究。
英文摘要
1. Studies on the acylation mechanism of alkylether phospholipids. We studied the acylation mechanism of 1-alkyl-glycerophosphocholine (GPC), using 1-alkyl-GPC as an acceptor and diacyl-GPC, including ^<14>C-arachidonic acid at the 2-position, as an acyl donor, by rabbit alveolar macrophage microsomes. This transacylation reaction does not need CoA, ATP or Mg^<2+>. C-20 fatty acids, especially arachidonic acid (20:4) and docosahexaenoic acid (22:6) are the good substrates for this enzymatic reaction.2. Release of arachidonic acid from alkylether phospholipids and incorporation of acetyl residue into 1-alkyl-GPC. Lyso platelet-activating factor (lyso PAF, 1-alkyl-GPC) produced by phospholipase A_2 action on ether choline glycerophospholipid (CGP) was acetylated or acylated by acetyltransferase or transacylase, competitively. The specific activity of acetyltransferase was 474 pmole/min/10^6cell lysate (acetylCoA; 100 m) and increased by 2-3 times on the cell stimulation with A23187. That of transacylase was 98 pmole/min/10^6cell lysate and significant increase of the activity was not observed on cell stimulation. on the other hand, the acetyltransferase activity was quite dependent on the concentration of acetyl-CoA in the case of no addition of exogenous acetyl-CoA. Therefore, in this case, lyso PAF seemed to be acylated mainly by transacylase with 20:4, rather than by acetyltransferase. The localization of these enzymes or substrates in cells shoud be studied in the next step.
期刊论文(24)
专著(0)
科研奖励(0)
会议论文
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
杉浦隆之、和久敬蔵: "「現代化学」増刊 血小板活性化因子(PAF)-生化学・生理・病理-第8章、生合成" 東京化学同人, (1989)
Takayuki Sugiura、Keizo Waku:“现代化学特别版血小板激活因子 (PAF) - 生物化学、生理学、病理学 - 第 8 章,生物合成” 东京化学同人社,(1989 年)
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
T.Sugiura;et al.: J.Biol.Chem. 1988. 263 (17490-17498)
T.Sugiura;等人:J.Biol.Chem。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
A.Ojima-Uchiyama;et al.: Lipids. 23. 815-817 (1988)
A.Ojima-Uchiyama 等人:脂质。
DOI: --
发表时间:
期刊:
影响因子: --
作者: []
通讯作者:
共 15 条
    Physiological roles of 2-arachidonoylglycerol in the nervous system and the immune system
    • 批准号:
      14580653
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $2.3万
    • 财政年份:
      2002
    • 负责人:
      WAKU Keizo
    • 依托单位:
    Several physiological functions of 2-arachido.noylglycerol; an endogenous cannabinoid receptor ligand
    • 批准号:
      12680640
    • 项目类别:
      Grant-in-Aid for Scientific Research (C)
    • 资助金额:
      $1.98万
    • 财政年份:
      2000
    • 负责人:
      WAKU Keizo
    • 依托单位:
    Study on the 2-arachidonoylglycerol, a novel endogenous cannabinoid receptor ligand
    • 批准号:
      10470488
    • 项目类别:
      Grant-in-Aid for Scientific Research (B)
    • 资助金额:
      $3.07万
    • 财政年份:
      1998
    • 负责人:
      WAKU Keizo
    • 依托单位:
    Healing of several PAF-derived diseases by newly disigned PAF antagonists
    国内基金
    海外基金
    Macrophage和Treg在移植免疫调节中的相互作用及其机制研究
    • 批准号:
      81102247
    • 项目类别:
      青年科学基金项目
    • 资助金额:
      25.0万元
    • 批准年份:
      2011
    • 负责人:
      丁晨光
    • 依托单位: